Vanderbilt Vaccine Research Program

Vaccine researchers ready as new flu strain evolves

A worrisome new avian influenza virus, called H7N9, emerged this spring in Eastern China.

CDC selects VU to lead national adverse vaccine event reviews

Vanderbilt University Medical Center has been selected by the Centers for Disease Control and Prevention (CDC), to lead a consortium of top national experts in vaccine safety in performing timely reviews of adverse vaccine events.

Pneumonia vaccine for children to be tested in older adults

Vanderbilt is taking part in a national study to test in older adults the use of a vaccine designed to protect children against a common cause of pneumonia.

1 2 3